盐酸曲美他嗪片说明书_中英文对照说明书

盐酸曲美他嗪片说明书_中英文对照说明书 盐酸曲美他嗪片说明书 请仔细阅读说明书并在医师指导下使用。 [药品名称] 通用名称:盐酸曲美他嗪片 商品名称:万爽力? 英文名称:Trimetazidine Dihydrochloride Tablets (VASOREL?) 汉语拼音:Yansuan Qumeitaqin Pian [成份] 化学名称:盐酸曲美他嗪，1-(2,3,4-三甲氧基苯甲基)哌嗪二盐酸盐 分子式:C14H22N2O3 ? 2HCl 分子量:339.3 [性状] 本品为薄膜衣片，除去薄膜衣后呈白色。 [适应症] 心绞痛发作的预防性治疗。眩晕和耳鸣的辅助性对症治疗。 [规格] 20mg [用法用量] 每24小时60mg:每日3次，每次1片，三餐时服用。 [不良反应] 罕见胃肠道不适(恶心，呕吐)。 由于辅料中有日落黄FCF S(E110)及胭脂红A(E124)成份，可能会发生过敏反应。 [禁忌] 对药品任一组份过敏者禁用。哺乳期通常不推荐使用(参见,孕妇及哺乳期妇女用药,)。 [注意事项] 此药不作为心绞痛发作时的对症治疗用药，也不适用于对不稳定心绞痛或心肌梗死的初始治疗。此药不应用于入院前或入院后最初几天的治疗。心绞痛发作时，对冠状动脉病况应重新评估，并考虑治疗的调整(药物治疗和可能的血运重建)。 [孕妇及哺乳期妇女用药] 妊娠 动物实验没有提示致畸作用;但是由于缺乏临床资料，致畸的危险不能排除。因此，从安全的角度考虑，最好避免在妊娠期间服用该药物。 哺乳 由于缺乏通过乳汁分泌的资料，建议治疗期间不要哺乳。 [儿童用药] 儿童用药的安全性和有效性尚未确定。 [老年用药] 参见其他项下内容或遵医嘱。 核准日期:2006-12-26236300002 [贮藏] 30?以下贮藏 [包装] 铝铝泡罩包装，15片，30片，60片/盒 [有效期] 36个月 [执行] YBHI13562005 [批准文号] 国药准字H20055465 [生产企业] Insert of Trimetazidine Dihydrochloride Tablets Carefully read insert and conform to the physician’s prescription. [Drug names] Generic name: Trimetazidine dihydrochloride tablets Trade name: VASOREL? English name: Trimetazidine Dihydrochloride Tablets (VASOREL?) Chinese Pinyin: Yansuan Qumeitaqin Pian [Ingredients] Chemical name: Trimetazidine dihydrochloride, 1-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride Molecular formula: C14H22N2O3?2HCl Molecular weight: 339.3 [Description] Film-coated tablet with white core [Indications] Prophylactic treatment of episodes of angina pectoris. Adjuvant symptomatic treatment of vertigo and tinnitus. [Strength] 20mg [Dosage and administration] 60 mg per 24 hours: 1 tablet to be taken 3 times a day at meal times. [Adverse reactions] Rare cases of gastrointestinal disorders (nausea and vomiting). Because of the presence of sunset yellow FCF S (E110) and cochineal red A (E124), risk of allergic reactions. [Contraindications] This drug should never be used in case of hypersensitivity to any one of the product's constituents. This drug is generally not recommended during breastfeeding (Cf. Pregnancy and lactation). [Precautions] This drug is not a curative treatment for angina attacks, nor is it indicated as initial treatment for unstable angina, or myocardial infarction. It should not be used in the pre-hospital phase nor during the first days of hospitalization; In the event of an angina attack, the coronaropathy should be reevaluated and an adaptation of the treatment considered (drug treatment and possibly revascularisation). [Pregnancy and lactation] Pregnancy Studies in animals have not demonstrated a teratogenic effect however, in the absence of clinical data, the risk of mal-formation cannot be excluded. Therefore, for safety reasons, it is preferable to avoid prescription during pregnancy. Breast feeding In the absence of data on excretion in breast milk, breastfeeding is not recommended during treatment. [Use in Children] Safety and effectiveness in pediatric patients have not been established. [Use in Elderly] See information in other items or follow physician’s instructions. [Storage] below [Package] Alu-Alu blister; 15, 30, 60 tablets/box [Shelf life] 36 months [Specification No.] YBH13562005 [Approval No.] 国药准字H20055465 [Manufacturer]